Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:20 PM
Ignite Modification Date:
2025-12-24 @ 12:20 PM
NCT ID:
NCT00909961
Eligibility Criteria:
Inclusion Criteria:
* Postmenopausal osteoporosis
* Patients who has a low bone mineral density at hip or vertebral
* Patients who has an osteoporotic fracture at hip or vertebra
Exclusion Criteria:
* Hypersensitivity either to the active substance or to any of the excipients or to any biphosphonates.
* Known metabolic bone disease excluding osteoporosis.
* Serious systemic disorder treated with drugs interfering with bone metabolism.
* Significant liver or renal failure
* Pathologic fracture in the examined body area or elsewhere.
* Previous anti-osteoporotic treatment within 12 months or less prior to the recruitment.
* Patients with hypocalcaemia
Other protocol-defined inclusion/exclusion criteria may apply
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
50 Years
Maximum Age:
65 Years
Study:
NCT00909961
Study Brief:
Protocol Section:
NCT00909961